OOIR: Observatory of International Research

Papers

(The H4-Index of CTS-Clinical and Translational Science is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer	515
Issue Information	202
Intradermal substance P as a challenge agent in healthy individuals	140
Issue Information	117
	94
ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study	87
A Patient Centric Model for Vaso‐Occlusive Crises in Sickle Cell Disease—Outcomes of a Consensus Exercise Conducted Across Patients and Experts	79
Bridging Implementation Gaps in Digital Health: A Translational Research Imperative for Equitable Healthcare Innovation	71
Japanese Phase 1 Study for Global Development of Anti‐TL1A Antibody PF‐06480605: A Randomized, Placebo‐Controlled, Single‐Ascending Dose Study	70
The impact of skin color and tone on histamine iontophoresis and Doppler flowmetry measurements as a pharmacodynamic biomarker	61
A comprehensive Thai pharmacogenomics database (TPGxD‐1): Phenotype prediction and variants identification in 942 whole‐genome sequencing data	60
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection	56
Patient, industry, and regulatory perspective on antibody‐drug conjugates dose optimization	55
Using partition analysis as a facile method to derive net clearances	51
Lexicon for blood‐based early detection and screening: BLOODPAC consensus document	48
First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome	48
Mitigating ipatasertib‐induced glucose increase through dose and meal timing modifications	45
Expanding regulatory science: Regulatory complementarity and reliance	45
The Effect of Diabetes Medication on the Scores of the GNRI and CONUT Nutritional Indices: Cross‐S	43
Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open‐Label Trial	41
Nontraditional Factors Influencing Cardiovascular Disease Risk: Correlation Among Framingham Risk Score, Body Composition Index, and Sleep‐Breathing Monitoring Index	37
CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin	37
Pharmacokinetics and Toxicity of Dimethylacetamide and Its Metabolite in Pediatric Patients Treated With High Dose Intravenous Busulphan	37
Developing a clinical research infrastructure embedded in an academic medicine center that equitably supports future clinician scientists	37
From Lab to Clinic: Effect of Academia–Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry	36

Generalizability in real‐world trials	33
Issue Information	32
First, Do No Harm: Addressing AI's Challenges With Out‐of‐Distribution Data in Medicine	32
	30
Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health System	30